Double blind randomized phase IV clinical trial to evaluate the efficacy of fluvastatin on inflammatory markers in the haemodynamic progression of degenerative aortic stenosis. The AORTICA 1 study.
Phase of Trial: Phase IV
Latest Information Update: 19 Jan 2018
At a glance
- Drugs Fluvastatin (Primary)
- Indications Aortic valve stenosis
- Focus Biomarker; Therapeutic Use
- Acronyms AORTICA-1
- 11 Jan 2018 Planned End Date changed from 1 Nov 2014 to 1 Jan 2018.
- 03 Mar 2007 New trial record.